These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29212881)

  • 1. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination.
    Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccination of very low birth weight infants at discharge from the NICU.
    Stumpf KA; Thompson T; Sánchez PJ
    Pediatrics; 2013 Sep; 132(3):e662-5. PubMed ID: 23940248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus Vaccination Can Be Performed Without Viral Dissemination in the Neonatal Intensive Care Unit.
    Hiramatsu H; Suzuki R; Nagatani A; Boda H; Miyata M; Hattori F; Miura H; Sugata K; Yamada S; Komoto S; Taniguchi K; Ihira M; Nishimura N; Ozaki T; Yoshikawa T
    J Infect Dis; 2018 Jan; 217(4):589-596. PubMed ID: 29165657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of rotavirus vaccine in the NICU.
    Monk HM; Motsney AJ; Wade KC
    Pediatrics; 2014 Jun; 133(6):e1555-60. PubMed ID: 24843056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
    JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects.
    Li Y; Sun X; Fu Y; You X; Hartwig S
    Vaccine; 2024 Mar; 42(7):1461-1468. PubMed ID: 38355319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccine strain transmission by vaccinated infants in the foster home.
    Miura H; Kawamura Y; Sugata K; Koshiyama N; Yoshikawa A; Komoto S; Taniguchi K; Ihira M; Yoshikawa T
    J Med Virol; 2017 Jan; 89(1):79-84. PubMed ID: 27335144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination.
    Briggs-Steinberg C; Shah S
    Am J Perinatol; 2018 Dec; 35(14):1443-1448. PubMed ID: 29883980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus shedding in premature infants following first immunization.
    Smith CK; McNeal MM; Meyer NR; Haase S; Dekker CL
    Vaccine; 2011 Oct; 29(45):8141-6. PubMed ID: 21856359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.